EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Curcumin-preconditioned bone marrow mesenchymal stem cell exosomes ameliorate postmenopausal osteoporosis by activating mitophagy in osteoblast-lineage cells

Chao Li, Xufeng Jiang, Kechong Zhou, Quan Sun, Huaqing Shen

Frontiers in Cell and Developmental Biology · 29.07.2026 · 14

DOI: 10.3389/fcell.2026.1891247 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Frontiers in Cell and Developmental Biology, online erschienen am 29.07.2026. Verfasst von Chao Li und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Orthopedics, Xiangyang Central Hospital, Affiliated Hospital of Hubei University of Arts and Science, Xiangyang, Hubei, China. Die Arbeit nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Postmenopausal osteoporosis, driven by oxidative stress and impaired osteoblast function, remains a major health crisis with limited anabolic therapies. Exosomes from curcumin-preconditioned mesenchymal stem cells (MSCs) are promising cell-free therapeutics, yet their cellular targets and molecular mechanisms remain elusive.

Methods

BMSCs were isolated, pretreated with curcumin, and exosomes were purified by ultracentrifugation. Exploratory scRNA-seq, in vitro H 2 O 2 stress assays, and ovariectomized (OVX) mouse models were employed.

Results

Curcumin pretreatment enhanced exosomal osteogenic potential without altering physicochemical properties. scRNA-seq identified osteoblast-lineage cells as major transcriptional responders. Cur-BMSC-Exo activated PINK1/Parkin-mediated mitophagy, eliminated damaged mitochondria, and restored mitochondrial function. This effect was abrogated by Mdivi1. Systemic Cur-BMSC-Exo administration significantly increased bone volume and trabecular thickness in OVX mice, whereas Mdivi1 abolished these benefits.

Conclusion

Cur-BMSC-Exo ameliorates osteoporosis by activating mitophagy in osteoblast-lineage cells, offering a novel cell-free therapeutic strategy.

Schlagwörter

Stichwörter der Autor:innen

PINK1/parkin pathwaycurcuminmesenchymal stem cell exosomesmitophagypostmenopausal osteoporosissingle-cell RNA sequencing

Autor:innen und Institutionen

  • Department of Orthopedics, Xiangyang Central Hospital, Affiliated Hospital of Hubei University of Arts and Science, Xiangyang, Hubei, China.
  • Department of Urology, Xiangyang Central Hospital, Affiliated Hospital of Hubei University of Arts and Science, Xiangyang, Hubei, China.

Zitieren

APA

Li, C., Jiang, X., Zhou, K., Sun, Q., & Shen, H. (2026). Curcumin-preconditioned bone marrow mesenchymal stem cell exosomes ameliorate postmenopausal osteoporosis by activating mitophagy in osteoblast-lineage cells. Frontiers in Cell and Developmental Biology, 14. https://doi.org/10.3389/fcell.2026.1891247

Vancouver

Li C, Jiang X, Zhou K, Sun Q, Shen H. Curcumin-preconditioned bone marrow mesenchymal stem cell exosomes ameliorate postmenopausal osteoporosis by activating mitophagy in osteoblast-lineage cells. Frontiers in Cell and Developmental Biology. 2026;14. doi:10.3389/fcell.2026.1891247

BibTeX
@article{Li2026,
  author = {Li, Chao and Jiang, Xufeng and Zhou, Kechong and Sun, Quan and Shen, Huaqing},
  title = {Curcumin-preconditioned bone marrow mesenchymal stem cell exosomes ameliorate postmenopausal osteoporosis by activating mitophagy in osteoblast-lineage cells},
  journal = {Frontiers in Cell and Developmental Biology},
  year = {2026},
  volume = {14},
  doi = {10.3389/fcell.2026.1891247}
}
Kostenlos starten →